Researchers from the VHIO, promoted by the “la Caixa” Foundation, have verified in patients with advanced tumours that a new…
Thursday, February 04 2021, not only celebrates World Cancer Day’s 21st birthday but also the final year of its ‘I…
Officially announced yesterday by ecancer, Prof. Gordon McVie has passed away. His departure represents a huge loss to all stakeholders…
Delivering on the European Society for Medical Oncology’s (ESMO) commitment to securing the best possible outcomes for people with cancer…
During 2021, the Vall d’Hebron Institute of Oncology will be the first center in Europe to establish a liquid biopsy…
*Source: EurOPDX Consortium Barcelona, January 8, 2021.- Cancer is one of the major causes of death in Europe. Therefore identification,…
While the rapidly emerging arsenal of immune-based therapies continues to show great promise in more effectively tackling an increasing number…
As a leading cause of cancer death worldwide, colorectal cancer (CRC) is the third most-common cancer globally. The mismatch repair…
The work, published in Frontiers in Oncology, emphasizes the role of the tumor microenvironment in response to treatments. Barcelona, December…
Peptomyc S.L., a spin-off from VHIO – the Vall d’Hebron Institute of Oncology – and ICREA – the Catalan Institute…
This may be gathered from the results of a study led by the Instituto de Investigación Biomédica de Bellvitge (IDIBELL)…
Published today in Cancer Cell* as a Spotlight piece, co-authors Josep Tabernero, VHIO’s Director, and Elena Élez, Clinical Investigator of…
